Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
We're excited to announce that we have recruited two cardiometabolic experts to our Medical City campus in Lake Nona (Orlando), Fla. Peter A. Crawford, M.D., Ph.D., and Andre d’Avignon, Ph.D., join our Cardiovascular Pathobiology Program from Washington University in St. Louis, Mo.
Sanford-Burnham’s NCI-Designated Cancer Center and the Cancer Center’s Community Advisory Board will host the second annual Cancer Center open house for cancer survivors, their families and friends, and research advocates on November 6 at 4:30 p.m. in La Jolla, Calif. The open house, titled “The Science Behind Melanoma,” will focus on revealing the latest discoveriesRead More
How beta-amyloid plaques are made in individuals with Down syndrome and Alzheimer's pateints.
Breast Cancer Awareness Month
A team of scientists around Sanford-Burnham's Ranjan Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of more-sensitive and specific non-invasive tests for prostate cancer than those currently available
Log in to leave a comment